Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Valeant to Borrow About $7 Billion for Bausch & Lomb Buyout

Don't Miss Out —
Follow us on:

May 27 (Bloomberg) -- Valeant Pharmaceuticals International Inc. said it secured debt financing from Goldman Sachs Group Inc. for $6.7 billion to $7.2 billion for its buyout of Bausch & Lomb Holdings Inc. Montreal-based Valeant will pay $4.5 billion for the eye-care company and spend $4.2 billion to repay Bausch & Lomb’s debt, the companies said in a statement. The deal will bring Valeant’s debt as a ratio of earnings before interest, taxes, depreciation and amortization to 4.6 times, according to the statement.

Link to Company News:{GS US <Equity> CN <GO>} Link to Company News:{VRX CN <Equity> CN <GO>}

To contact the editor responsible for this story: Cecile Gutscher at cgutscher@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.